de Jong, Edwin <br/><br/>
Anticancer effects of 15d-prostaglandin-J2 in wild-type and doxorubicin-resistant ovarian cancer cells: novel actions on SIRT1 and HDAC.  [electronic resource] 

 -  PloS one  2011 
 - e25192 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1932-6203 
<br/><br/><label>Standard No.: </label>10.1371/journal.pone.0025192  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>ATP Binding Cassette Transporter, Subfamily B, Member 1--genetics<br/>Antineoplastic Agents--chemistry<br/>Apoptosis--drug effects<br/>Cell Line, Tumor<br/>Doxorubicin--pharmacology<br/>Drug Resistance, Neoplasm--drug effects<br/>Female<br/>Gene Expression Regulation, Neoplastic--drug effects<br/>Histone Deacetylase Inhibitors--chemistry<br/>Histone Deacetylases--genetics<br/>Humans<br/>NF-kappa B--metabolism<br/>Ovarian Neoplasms--pathology<br/>Prostaglandin D2--analogs & derivatives<br/>Prostaglandin-Endoperoxide Synthases--metabolism<br/>Proto-Oncogene Proteins c-bcl-2--genetics<br/>RNA, Messenger--genetics<br/>Signal Transduction--drug effects<br/>Sirtuin 1--antagonists & inhibitors<br/>Structure-Activity Relationship<br/>Wound Healing--drug effects<br/>bcl-X Protein--genetics